1Department of Neurosurgery, Stanford University, Stanford, California.
2Department of Neurosurgery, Cabrini and Austin Health, Melbourne, Victoria, Australia.
J Neurosurg. 2023 Aug 11;140(2):489-497. doi: 10.3171/2023.6.JNS23702. Print 2024 Feb 1.
Ulnar neuropathy at the elbow (UNE) is common, affecting 1%-6% of the population. Despite this, there remains a lack of consensus regarding optimal treatment. This is primarily due to the difficulty one encounters when trying to assess the literature. Outcomes are inconsistently reported, which makes comparing studies or developing meta-analyses difficult or even impossible. Thus, there is a need for a core outcome set (COS) for UNE (COS-UNE) to help address this problem. The objective of this study was to utilize a modified Delphi method to develop COS-UNE.
A 5-stage approach was utilized to develop COS-UNE: stage 1, consortium development; 2, literature review to identify potential outcome measures; 3, Delphi survey to develop consensus on outcomes for inclusion; 4, Delphi survey to develop definitions; and 5, consensus meeting to finalize the COS and definitions. The study followed the Core Outcome Set-STAndards for Development (COS-STAD) recommendations.
The Core Outcomes in Nerve Surgery (COINS) Consortium comprised 21 participants, all neurological surgeons representing 11 countries. The final COS-UNE consisted of 22 data points/outcomes covering the domains of demographic characteristics, diagnostics, patient-reported outcomes, motor/sensory outcomes, and complications. Appropriate instruments, methods of testing, and definitions were set. The consensus minimum duration of follow-up was 6 months, with the consensus optimal timepoints for assessment identified as preoperatively and 3, 6, and 12 months postoperatively.
The authors identified consensus data points/outcomes and also provided definitions and specific scales to be utilized to help ensure that clinicians are consistent in their reporting across studies on UNE. This COS should serve as a minimum set of data to be collected in all future neurosurgical studies on UNE. The authors hope that clinicians evaluating ulnar neuropathy will incorporate this COS into routine practice and that future studies will consider this COS in the design phase.
肘部尺神经病变(UNE)很常见,影响 1%-6%的人群。尽管如此,对于最佳治疗方法仍缺乏共识。这主要是因为在尝试评估文献时遇到困难。结果报告不一致,这使得比较研究或进行荟萃分析变得困难甚至不可能。因此,需要为 UNE 制定一个核心结局集(COS-UNE)来解决这个问题。本研究旨在利用改良 Delphi 方法制定 COS-UNE。
采用 5 阶段方法制定 COS-UNE:第 1 阶段,联盟发展;第 2 阶段,文献综述以确定潜在的结局测量指标;第 3 阶段,Delphi 调查以就纳入的结局达成共识;第 4 阶段,Delphi 调查以制定定义;第 5 阶段,共识会议以最终确定 COS 和定义。该研究遵循核心结局集合-标准开发(COS-STAD)建议。
包括 21 名参与者的神经外科核心结局(COINS)联盟,所有参与者均为代表 11 个国家的神经外科医生。最终的 COS-UNE 包括 22 个数据点/结局,涵盖人口统计学特征、诊断、患者报告结局、运动/感觉结局和并发症领域。确定了适当的工具、测试方法和定义。一致认为,最低随访时间为 6 个月,最佳评估时间点为术前以及术后 3、6 和 12 个月。
作者确定了共识数据点/结局,并提供了定义和特定量表,以帮助确保临床医生在关于 UNE 的研究中报告的一致性。这个 COS 应该作为所有未来神经外科关于 UNE 研究中要收集的最小数据集。作者希望评估尺神经病变的临床医生将这个 COS 纳入常规实践中,未来的研究将在设计阶段考虑这个 COS。